- we represented Medinol, the medical products manufacturer in German and Dutch cross-border proceedings
- we assisted 3M in parallel patent litigation in Italy and Germany
- we represent EV3/MTI in cross border patent proceedings relating to endovascular coils in the Netherlands, Germany and at the European Patent Office
- we represented Organon N.V. in the enforcement of a process patent for a leading oral contraceptive in France and Germany
- we acted for Merck & Co, defending its patent for the osteoporosis drug, "Fosamax" in the UK High Court and the Court of Appeal
- we give strategic cross border patent enforcement advice to the leading manufacturer of bicycle components out of England, Belgium and Germany
- we advised GlaxoSmithKline on their Paroxetine off-patent strategy and litigation in the Netherlands
- we acted for Core and L&L against Möller in actions in Germany and the UK for alleged patent infringement relating to reinforcement parts for cars
- we acted for Etablissement Français du Sang against Octapharma concerning a biotechnological process for the preparation of blood factors
- we acted for Schering-Plough in off-patent litigation regarding Loratadine
- we are acting for Merck & Co in the High Court of Hong Kong in relation to infringement of its patent for Lovastatin
- we acted for Sankyo in China to enforce pipeline protection certificates for Pravastatin
- we represented the major Korean company Daesang on an integrated, cross-border patent dispute tried in the UK and the Netherlands about the artificial sweetener, aspartame
- we acted for Merck & Co in three jurisdictions (including Hong Kong) on claims relating to Simvastatin (Zocor), the market leading cholesterol drug
- we successfully handled the first patent trial after the handover of Hong Kong to the PRC.
Our
transactional experience includes many important transactions involving patent rights.